Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety, Efficacy and Pharmacokinetics of Lubiprostone in Paediatric Functional Constipation
2013-004384-31Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of cobiprostone in functional constipation (FC), sponsored by Mallinckrodt Pharmaceuticals. Primary endpoints: Long-term safety of lubiprostone, Efficacy of lubiprostone and 1 more. Started Feb 2014; status: completed.
02
Drugs
cobiprostone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on 2013-004384-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004384-31.